Autonomix Medical (AMIX) Net Income towards Common Stockholders (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Net Income towards Common Stockholders data on file, last reported at -$3.3 million in Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders fell 20.24% year-over-year to -$3.3 million in Q4 2025; TTM through Dec 2025 was -$17.2 million, a 26.52% decrease from a year earlier, with the FY2025 full-year figure at -$11.4 million, up 26.03% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at -$3.3 million, up from -$7.5 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for AMIX reached as high as -$544000.0 in Q4 2022 and fell as low as -$7.5 million in Q3 2025.
• Historically, Net Income towards Common Stockholders has averaged -$3.2 million across 4 years, with a median of -$3.1 million in 2023.
• On a YoY basis, Net Income towards Common Stockholders climbed as much as 53.53% in 2024 and fell as far as 723.14% in 2024.
• Year by year, Net Income towards Common Stockholders stood at -$544000.0 in 2022, then tumbled by 472.24% to -$3.1 million in 2023, then rose by 12.88% to -$2.7 million in 2024, then dropped by 20.24% to -$3.3 million in 2025.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$3.3 million in Q4 2025, -$7.5 million in Q3 2025, and -$3.3 million in Q2 2025.